Natco launches generic drug for sclerosis in India
April 05, 2018 | Thursday | News
The company has launched the product under brand name 'Denopsy'
Image Courtesy- medscape.com
Drug firm Natco Pharma has launched a generic version of Teriflunomide tablets used for the treatment of relapsing and remitting forms of multiple sclerosis in India.
The company has launched the product under brand name 'Denopsy', Natco Pharma said.
"This is the first oral medicine for relapsing and remitting forms of multiple sclerosis being offered in India at two different strengths - 14 mg and 7 mg tablets" it added.
Teriflunomide is sold by Sanofi-Genzyme under the brand name of Aubagio in the US market, Natco Pharma said.
The generic product is priced much lower than other alternate options in India.
